You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Clinical oncology

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2(Human Epidermal Growth Factor Receptor 2) -Positive

Not yet recruiting
  • Breast Cancer
    • Arkhangelsk, Russian Federation
    • +27 more
    Jun 13, 2023

    Epidemiology of TNBC in Asyut Clinical Oncology Department

    Not yet recruiting
    • Breast Cancer
      • (no location specified)
      Oct 15, 2022

      Radiotherapy & Total Neoadjuvant Therapy for Recurrent Rectal

      Recruiting
      • Rectal Neoplasm
      • Reirradiation
      • Rome, Italy
        Fondazione Policlinico Gemelli
      Aug 2, 2023

      Advanced Melanoma Trial in Belarus, Russian Federation (BCD-263, Opdivo)

      Recruiting
      • Advanced Melanoma
      • Minsk, Belarus
      • +29 more
      Nov 2, 2023

      Luminal Metastatic breAst caNcer in Real-life Clinical pracTice

      Completed
      • HR+/HER2- Breast Cancer
      • +2 more
      • Moscow, Russian Federation
        Russian Society of Clinical Oncology
      Mar 29, 2023

      NSCLC Metastatic Trial in Naestved, Aalborg, Vejle (Circulating tumor DNA treatment monitoring)

      Not yet recruiting
      • Non-small Cell Lung Cancer Metastatic
      • Circulating tumor DNA treatment monitoring
      • Naestved, Zealand, Denmark
      • +2 more
      May 25, 2023

      Drug Shortages on Oncology Care Delivery

      Active, not recruiting
      • Community Practice
      • Staff
      • Survey Administration
      • Minneapolis, Minnesota
      • +5 more
      Jan 26, 2023

      NSCLC Trial in Worldwide (JTX-4014, Vopratelimab)

      Active, not recruiting
      • NSCLC
      • Minsk, Belarus
      • +70 more
      Jan 18, 2023

      HCC Trial in Hong Kong (Zabadinostat (CXD101) and Geptanolimab, Lenvatinib and Sorafenib)

      Not yet recruiting
      • HCC
      • Zabadinostat (CXD101) and Geptanolimab
      • Lenvatinib and Sorafenib
      • Hong Kong, Hong Kong
        Department of Clinical Oncology, Prince of Wales Hospital
      May 15, 2023

      Periprosthetic Joint Infection Trial (Chlorhexidine Gluconate, Vancomycin Hydrochloride, Povidone-Iodine)

      Not yet recruiting
      • Periprosthetic Joint Infection
      • Chlorhexidine Gluconate
      • +3 more
      • (no location specified)
      Nov 14, 2023

      Resectable Melanoma, Melanoma Stage III, Melanoma (Skin) Trial in Belarus, Russian Federation (BCD-217, anti-PD1, Excision of

      Recruiting
      • Resectable Melanoma
      • +2 more
      • BCD-217
      • +3 more
      • Lesnoy, Belarus
      • +35 more
      Feb 21, 2023

      Melanoma, Melanoma (Skin), Melanoma Stage III Trial in Belarus, India, Russian Federation (BCD-217, BCD-100, Placebo)

      Recruiting
      • Melanoma
      • +6 more
      • BCD-217
      • +2 more
      • Babruysk, Belarus
      • +62 more
      Feb 8, 2023

      Postoperative Outcomes in Primary Lung Cancer

      Completed
      • Lung Cancer
      • Nutridrink Compact Protein
      • Omsk, Russian Federation
      • +3 more
      Feb 2, 2023

      Unresectable or Metastatic Melanoma Trial in Russian Federation (Prolgolimab)

      Active, not recruiting
      • Unresectable or Metastatic Melanoma
      • Arkhangel'sk, Russian Federation
      • +5 more
      Mar 23, 2023

      Genome Instability, Genetic Predisposition to Disease, Gene Rearrangement Trial in Rome (Diagnostic Test)

      Recruiting
      • Genome Instability
      • +2 more
      • Diagnostic Test
      • Rome, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Aug 30, 2023

      Neck Cancer Trial in Moscow (Pembrolizumab)

      Recruiting
      • Neck Cancer
      • Moscow, Russian Federation
      • +2 more
      Sep 21, 2022

      Clinical, patHOlogical and Imaging Project of nEuro-oncology

      Recruiting
      • Glioma
      • This study does not intervene in this process.
      • Beijing, Beijing, China
        Beijing Tiantan Hospital
      May 16, 2023

      Ovarian Cancer, Platinum-resistant Ovarian Cancer Trial in Minsk (Gemcitabine, ELENAGEN)

      Active, not recruiting
      • Ovarian Cancer
      • Platinum-resistant Ovarian Cancer
      • Minsk, Belarus
        Minsk City Clinical Oncology Center
      Jul 27, 2023

      Molecular Profiling Project

      Recruiting
      • Lung Cancer
      • Non-Small Cell Lung Cancer
        • Brunei, Brunei Darussalam
        • +9 more
        Oct 2, 2022

        Squamous Cell Carcinoma of the Oral Cavity Trial in Worldwide (GL-0817, Hiltonol, Sargramostim)

        Completed
        • Squamous Cell Carcinoma of the Oral Cavity
        • Baltimore, Maryland
        • +32 more
        Mar 4, 2022

        Nasopharyngeal Cancer Trial in Hong Kong (Adjuvant chemo (gemcitabine and cisplatin))

        Completed
        • Nasopharyngeal Cancer
        • Adjuvant chemotherapy (gemcitabine and cisplatin)
        • Hong Kong, Hong Kong
        • +5 more
        Feb 15, 2022

        NSCLC Trial in Russian Federation (Bevacizumab, Paclitaxel, Carboplatin)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • Arkhangel'sk, Russian Federation
        • +10 more
        Dec 8, 2022

        Palliative Oncology Setting? A Pragmatic Clinical Trial

        Not yet recruiting
        • Cancer
          • London, Ontario, Canada
            London Regional Cancer Program, London Health Sciences Centre
          Dec 4, 2023

          Oncology Trial in London (NAVIFY Oncology Hub)

          Active, not recruiting
          • Oncology
          • NAVIFY Oncology Hub
          • London, United Kingdom
            Prova Health Limited
          Jul 27, 2022

          Advanced/Metastatic Solid Tumors Trial in Australia, China (ATG-022)

          Not yet recruiting
          • Advanced/Metastatic Solid Tumors
          • Adelaide, Australia
          • +3 more
          Jan 30, 2023